Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(7):S29–S32. doi: 10.1155/S0962935193000729

L-carnitine: a partner between immune response and lipid metabolism ?

Giuseppe Famularo 2,✉, Sonia Tzantzoglou 3, Gino Santini 3, Vito Trinchieri 3, Sonia Moretti 3, Aleardo Koverech 4, Claudio De Simone 1
PMCID: PMC2365452  PMID: 18475566

Abstract

The authors demonstrated that in vivo administered L-carnitine strongly ameliorated the immune response in both healthy individuals receiving Intralipid and ageing subjects with cardiovascular diseases, as shown by the enhancement of mixed lymphocyte reaction. Notably, in the latter group L-carnitine treatment also resulted in a significant reduction of serum levels of both cholesterol and triglycerides. Therefore, the hypothesis is that L-carnitine supplementation could ameliorate both the dysregulated immune response and the abnormal lipid metabolism in several conditions.

Full Text

The Full Text of this article is available as a PDF (346.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bremer J. Carnitine--metabolism and functions. Physiol Rev. 1983 Oct;63(4):1420–1480. doi: 10.1152/physrev.1983.63.4.1420. [DOI] [PubMed] [Google Scholar]
  2. Bremer J. The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem. 1990 May;28(5):297–301. [PubMed] [Google Scholar]
  3. Chapoy P. R., Angelini C., Brown W. J., Stiff J. E., Shug A. L., Cederbaum S. D. Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome. N Engl J Med. 1980 Dec 11;303(24):1389–1394. doi: 10.1056/NEJM198012113032403. [DOI] [PubMed] [Google Scholar]
  4. Deufel T. Determination of L-carnitine in biological fluids and tissues. J Clin Chem Clin Biochem. 1990 May;28(5):307–311. [PubMed] [Google Scholar]
  5. Engel A. G., Rebouche C. J. Carnitine metabolism and inborn errors. J Inherit Metab Dis. 1984;7 (Suppl 1):38–43. doi: 10.1007/BF03047372. [DOI] [PubMed] [Google Scholar]
  6. Famularo G., Giacomelli R., Di Giovanni S., Sacchetti S., Tonietti G. Cytokine production in patients with monoclonal gammapathies. J Clin Lab Immunol. 1991 Feb;34(2):63–69. [PubMed] [Google Scholar]
  7. Feller A. G., Rudman D. Role of carnitine in human nutrition. J Nutr. 1988 May;118(5):541–547. doi: 10.1093/jn/118.5.541. [DOI] [PubMed] [Google Scholar]
  8. Gilbert E. F. Carnitine deficiency. Pathology. 1985 Apr;17(2):161–171. doi: 10.3109/00313028509063752. [DOI] [PubMed] [Google Scholar]
  9. Haeckel R., Kaiser E., Oellerich M., Siliprandi N. Carnitine: metabolism, function and clinical application. J Clin Chem Clin Biochem. 1990 May;28(5):291–295. [PubMed] [Google Scholar]
  10. Rebouche C. J., Engel A. G. Tissue distribution of carnitine biosynthetic enzymes in man. Biochim Biophys Acta. 1980 Jun 5;630(1):22–29. doi: 10.1016/0304-4165(80)90133-6. [DOI] [PubMed] [Google Scholar]
  11. Siliprandi N., Di Lisa F., Menabó R., Ciman M., Sartorelli L. Transport and functions of carnitine in muscles. J Clin Chem Clin Biochem. 1990 May;28(5):303–306. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES